Denufosol
id:
denufosol-233-4461773
title:
Denufosol
text:
Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation. It was tested in two Phase III clinical trials, TIGER-1 and TIGER-2. Initially, in the first Phase III trial, TIGER-1, the compound showed significant results as compared with placebo. In the second Phase III trial, TIGER-2, the compound did not meet the primary endpoint, a significant change in baseline FEV1 at the week 48 endpoint
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Denufosol
date created:
date modified:
2023-04-11T14:50:12Z
main entity:
{"identifier":"Q908026","url":"https://www.wikidata.org/entity/Q908026"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/ba/Denufosol.svg","width":522,"height":218}
fields total:
13
integrity:
15